CIRS

AirAnswers Expands its Leading Air Diagnostic Capability with New Laboratory Tests Designed to Address the Needs of Integrative Medicine Providers

Retrieved on: 
Wednesday, November 1, 2023

CHICAGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- AirAnswers®, the leader in air sampling and testing technology, is expanding its test offering to include new HERTSMI-2 and FUNGITEN Tests.

Key Points: 
  • CHICAGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- AirAnswers®, the leader in air sampling and testing technology, is expanding its test offering to include new HERTSMI-2 and FUNGITEN Tests.
  • These tests can detect critical species of airborne mold associated with damp buildings, mycotoxins and CIRS symptoms.
  • “This expansion of the AirAnswers test offering emphasizes the flexibility of this technology and expands the contributions AirAnswers will make to indoor air quality,” says Jim Koziarz, CEO of AirAnswers.
  • “Effective air management requires the accurate assessment of air quality and the AirAnswers technology is a key element in the Assess-Remediate-Monitor model.

Sun Nuclear Showcases Evolving and Expanding Quality Management Portfolio at ESTRO 2023 Meeting

Retrieved on: 
Friday, May 12, 2023

MELBOURNE, Fla., May 12, 2023 /PRNewswire/ -- Sun Nuclear, a Mirion Medical company (Mirion, NYSE: MIR), will highlight the latest innovations for Quality Management at the ESTRO Annual Meeting beginning Friday, May 12, in Vienna, Austria. Industry gold standard and novel Radiation Therapy and Diagnostic Imaging QA solutions will be featured in ESTRO booth #150 throughout the meeting, with product demonstrations and user presentations.

Key Points: 
  • MELBOURNE, Fla., May 12, 2023 /PRNewswire/ -- Sun Nuclear , a Mirion Medical company (Mirion, NYSE: MIR), will highlight the latest innovations for Quality Management at the ESTRO Annual Meeting beginning Friday, May 12, in Vienna, Austria.
  • On Sunday, May 14, Sun Nuclear will hold its annual lunch symposium, featuring insights from leaders in the field of Radiation Therapy.
  • Automated, Integrated Quality Management: The SunCHECK Platform powers Quality Management, with centralized, standardized Patient and Machine QA for Radiation Therapy programs.
  • ESTRO attendees will notice new branding reflected in the Sun Nuclear booth and the inclusion of CIRS solutions, which are now part of the Sun Nuclear brand.

Safestart Environmental™ Teams Up with AirAnswers® Air Diagnostics™ to Deliver Comprehensive Indoor Air Testing Solutions for Improved Health and Well-being

Retrieved on: 
Thursday, April 20, 2023

AirAnswers and Safestart Environmental join forces to identify and eliminate airborne indoor biological contaminants that leave clients susceptible to environmentally acquired illnesses such as sick building syndrome, chronic fatigue syndrome, and CIRS.

Key Points: 
  • AirAnswers and Safestart Environmental join forces to identify and eliminate airborne indoor biological contaminants that leave clients susceptible to environmentally acquired illnesses such as sick building syndrome, chronic fatigue syndrome, and CIRS.
  • By implementing AirAnswers® Air DiagnosticTM system into their assessments, Safestart Environmental can identify biological contaminants in the air and provide targeted solutions to optimize their clients’ indoor environmental health.
  • AirAnswers technology provides users the ability to assess, remediate, and monitor indoor spaces for the presence of biological contaminants.
  • AirAnswers laboratory testing can provide specific information that will directly result in improved conditions for our clients.

Expanded Portfolio for Better Quality Management from Sun Nuclear at the 2022 ASTRO Annual Meeting

Retrieved on: 
Friday, October 21, 2022

MELBOURNE, Fla., Oct. 21, 2022 /PRNewswire/ -- Sun Nuclear, a wholly-owned subsidiary of Mirion Technologies, Inc. (NYSE: MIR) ("Mirion"), will present its comprehensive Quality Management portfolio, with expanded offerings from CIRS, now part of Sun Nuclear, at the ASTRO Annual Meeting, October 23-25, 2022, in San Antonio, Texas. Highlights in the Sun Nuclear booth (980) include the SunCHECK® Platform, new SunSCAN™ 3D System, and the first joint QA solution from Sun Nuclear and CIRS.

Key Points: 
  • MELBOURNE, Fla., Oct. 21, 2022 /PRNewswire/ -- Sun Nuclear , a wholly-owned subsidiary of Mirion Technologies, Inc. (NYSE: MIR) ("Mirion"), will present its comprehensive Quality Management portfolio, with expanded offerings from CIRS, now part of Sun Nuclear, at the ASTRO Annual Meeting , October 23-25, 2022, in San Antonio, Texas.
  • From practical resources for motion and MRgRT QA to advanced tissue simulation capabilities and anthropomorphic phantom design, an expanded portfolio, with demos, will be on display in the Sun Nuclear ASTRO booth.
  • Also on display in the Sun Nuclear ASTRO booth will be the work-in-progress MotionCHECK 3D System.
  • Sun Nuclear will also have a booth at the 2022 Annual Society for Radiation Oncology Administrators Meeting , where attendees can learn how Sun Nuclear can help them reduce risks, control costs, and improve treatment quality.

Sun Nuclear Partners with Accuray to Develop New Quality Management Solutions for the Radixact® System with Synchrony®

Retrieved on: 
Wednesday, October 19, 2022

MELBOURNE, Fla., Oct. 19, 2022 /PRNewswire/ -- Sun Nuclear, a wholly-owned subsidiary of Mirion Technologies, Inc. (NYSE: MIR) ("Mirion"), today announced that it is developing new Quality Management solutions, in collaboration with Accuray, for the company's Radixact® System with Synchrony®, which enables real-time, personalized adaptive radiation therapy. Initial innovations from the collaboration will be featured in the Sun Nuclear booth (980) at the ASTRO Annual Meeting, October 23-25, 2022, in San Antonio, Texas.

Key Points: 
  • It enables movement of compatible phantoms with sub-millimeter accuracy and reproducibility, easing quality assurance (QA) and boosting clinical confidence for advanced tumor treatments.
  • Also on display in the Sun Nuclear ASTRO booth will be the work-in-progress MotionCHECK 3D System.
  • "We are excited to highlight the Enhanced Dynamic Platform and MotionCHECK 3D system at ASTRO," notes Mark Rose, Ph.D., Sun Nuclear Director of Product Management.
  • "We have collaborated often with Sun Nuclear on QA solutions specific to the technologies that Accuray produces.

Sun Nuclear Awarded ISO/IEC 27001:2013 Certification

Retrieved on: 
Thursday, September 22, 2022

MELBOURNE, Fla., Sept. 22, 2022 /PRNewswire/ -- Sun Nuclear, a wholly-owned subsidiary of Mirion Technologies, Inc. (NYSE: MIR) ("Mirion"), today announced that it has achieved ISO/IEC 27001:2013 certification for its information security management system (ISMS). The certification confirms Sun Nuclear has met the highest possible international standards for managing sensitive organizational and customer information across its facilities in the U.S., Germany, and the Netherlands. Certification also extends to the design, development, and Cloud-based, software-as-a-service (SaaS) deployment of the SunCHECK® Platform – a single-database, single-interface solution for automated Patient and Machine Quality Assurance (QA) in Radiation Therapy.

Key Points: 
  • The certification confirms Sun Nuclear has met the highest possible international standards for managing sensitive organizational and customer information across its facilities in the U.S., Germany, and the Netherlands.
  • Sun Nuclear is one of only a few companies in the Radiation Oncology field to achieve the rigorous ISO 27001:2013 certification, and the sole certified company focused exclusively on QA.
  • With certification for the SunCHECK Platform and its SaaS implementation option , new users can be assured of software reliability and security.
  • Sun Nuclear's certification was issued by SGS, the world's leading testing, inspection and certification company, recognized as the global benchmark for quality and integrity.

CIRS Dosimetric Verification Phantoms Set for Artemis I Space Flight

Retrieved on: 
Thursday, August 25, 2022

MELBOURNE, Fla., Aug. 25, 2022 /PRNewswire/ -- Sun Nuclear, a wholly-owned subsidiary of Mirion Technologies, Inc. (NYSE: MIR) ("Mirion"), today announced its ATOM® Phantom product line will play a vital role in the first of a series of NASA missions aimed at enabling human exploration to the Moon and Mars. The uncrewed Artemis I mission, scheduled for launch on August 29th, will serve as the first integrated test of NASA's deep space exploration systems, including the Orion spacecraft. Two custom, anthropomorphic ATOM Phantoms will ride as "passengers" aboard the Orion, to assist in measuring potential radiation exposure to astronauts.

Key Points: 
  • Two custom, anthropomorphic ATOM Phantoms will ride as "passengers" aboard the Orion, to assist in measuring potential radiation exposure to astronauts.
  • ATOM Phantoms are designed and produced by CIRS, now part of Sun Nuclear , a global leader in Quality Management solutions for Radiation Therapy and Diagnostic Imaging.
  • Following a CIRS tradition when shipping ATOM Phantoms to customers worldwide, the space-bound phantoms were given names Helga and Zohar.
  • "With the historic Artemis I mission and its inclusion of ATOM Phantoms, CIRS and Sun Nuclear continue the longstanding engagement of Mirion to make space exploration safer, and to support interplanetary scientific voyages."

Mirion Technologies Announces Mirion Medical Brand

Retrieved on: 
Tuesday, July 5, 2022

Mirion Technologies, Inc. (NYSE: MIR) (Mirion), today announced the rebranding of its Medical segment as the Mirion Medical group, comprised of the organizations healthcare-focused Dosimetry Services, Sun Nuclear, CIRS, Biodex, and Capintec business units.

Key Points: 
  • Mirion Technologies, Inc. (NYSE: MIR) (Mirion), today announced the rebranding of its Medical segment as the Mirion Medical group, comprised of the organizations healthcare-focused Dosimetry Services, Sun Nuclear, CIRS, Biodex, and Capintec business units.
  • The establishment of the Mirion Medical group reinforces the Mirion commitment to leveraging its expertise in ionizing radiation for healthcare applications.
  • With the introduction of the Mirion Medical brand, CIRS solutions will integrate into the Sun Nuclear brand.
  • The establishment of Mirion Medical will not change how Mirion Technologies reports financial performance externally, or how the Industrial group operates.

Sun Nuclear Highlights New SunSCAN™ 3D System & Smart Quality Management Solutions at ESTRO 2022

Retrieved on: 
Thursday, May 5, 2022

MELBOURNE, Fla., May 5, 2022 /PRNewswire/ -- Sun Nuclear Corporation (Sun Nuclear), a wholly-owned subsidiary of Mirion Technologies, Inc. (NYSE: MIR) ("Mirion"), will feature its comprehensive solutions portfolio for independent, integrated Quality Management of Radiation Therapy and Diagnostic Imaging at the ESTRO 2022 Congress, held May 6-10 in Copenhagen, Denmark. ESTRO will mark the first live showing of the new SunSCAN™ 3D Cylindrical Water Scanning System. Throughout ESTRO in the Sun Nuclear booth (Hall C 1010), the company will feature: the SunSCAN 3D System; SunCHECK™ Platform; new CIRS solutions joining the Sun Nuclear portfolio; expanded offerings for stereotactic and MR-guided treatments; and a series of educational presentations and product demonstrations.

Key Points: 
  • ESTRO will mark the first live showing of the new SunSCAN 3D Cylindrical Water Scanning System .
  • The new SunSCAN 3D System will be revealed at 18:05 during the ESTRO opening reception and will be on display in the Sun Nuclear booth throughout ESTRO.
  • CIRS extends the Sun Nuclear Quality Management offering with renowned tissue simulation technology, anthropomorphic phantoms, and comprehensive testing and verification solutions.
  • ESTRO attendees are invited to join the Sun Nuclear satellite symposium, Smarter Quality Management: Innovations & Insights, on May 8, beginning at 13:00 in auditorium 11, for highlights on the latest advancements for Quality Management.

Sun Nuclear Highlights New SunSCAN™ 3D System & Smart Quality Management Solutions at ESTRO 2022

Retrieved on: 
Thursday, May 5, 2022

MELBOURNE, Fla., May 5, 2022 /PRNewswire/ -- Sun Nuclear Corporation (Sun Nuclear), a wholly-owned subsidiary of Mirion Technologies, Inc. (NYSE: MIR) ("Mirion"), will feature its comprehensive solutions portfolio for independent, integrated Quality Management of Radiation Therapy and Diagnostic Imaging at the ESTRO 2022 Congress, held May 6-10 in Copenhagen, Denmark. ESTRO will mark the first live showing of the new SunSCAN™ 3D Cylindrical Water Scanning System. Throughout ESTRO in the Sun Nuclear booth (Hall C 1010), the company will feature: the SunSCAN 3D System; SunCHECK™ Platform; new CIRS solutions joining the Sun Nuclear portfolio; expanded offerings for stereotactic and MR-guided treatments; and a series of educational presentations and product demonstrations.

Key Points: 
  • ESTRO will mark the first live showing of the new SunSCAN 3D Cylindrical Water Scanning System .
  • The new SunSCAN 3D System will be revealed at 18:05 during the ESTRO opening reception and will be on display in the Sun Nuclear booth throughout ESTRO.
  • CIRS extends the Sun Nuclear Quality Management offering with renowned tissue simulation technology, anthropomorphic phantoms, and comprehensive testing and verification solutions.
  • ESTRO attendees are invited to join the Sun Nuclear satellite symposium, Smarter Quality Management: Innovations & Insights, on May 8, beginning at 13:00 in auditorium 11, for highlights on the latest advancements for Quality Management.